What is Ambros Therapeutics worth?
$250.0Mlast known valuation
Ambros Therapeutics last raised $154.0M in its Early Stage VC (Series A) (Dec 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Ambros Therapeutics
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Dec 2025 | Early Stage VC (Series A) | $154.0M | ▮ | ▮ |
How Ambros Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Ambros Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Ambros Therapeutics worth?
- Ambros Therapeutics's last known valuation is $250.0M.
- How much has Ambros Therapeutics raised?
- Ambros Therapeutics has raised $154.0M in total funding across 1 recorded rounds.
- When did Ambros Therapeutics last raise?
- Ambros Therapeutics last raised in Dec 2025 (Early Stage VC (Series A)), raising $154.0M.